In practice, any side effects are usually due to injection technique, contamination, or the medication its mixed with
I'm not so concerned that these actual compounds are necessarily harming people
10.3969/j.issn.1672-2779.2016.19.022 279 ZhaoQ.ZhiB
10 Semaglutide is dosed initially at 0.25 mg subcutaneously once weekly and incrementally escalated weekly until a dose of 1.0 mg once weekly is reached
Coskuns research contributions include: Preclinical characterization of GLP2s dual receptor agonism and pharmacological properties Elucidation of the complementary mechanisms by which GIP and GLP-1 receptor activation produce synergistic metabolic effects Investigation of GLP2s effects on glucose homeostasis, body weight regulation, and energy expenditure in animal models Development of the scientific rationale supporting GLP2s advancement into human clinical trials Publication of seminal research establishing GLP2s unique pharmacological profile as an imbalanced dual agonist His work has contributed significantly to advancing understanding of incretin biology and establishing GLP2 as the prototype for a new therapeutic class in metabolic disease treatment
Here is the full comparison: efficacy, dose timing, side effects, cost